Fundamentals

Valuation

Metric	Q1	Q3	Δ in %
EV/EBITDA	552.05	627.18	96.19
Graham Fair Price	44.67	1.88	1.30
PEG	-79.04	0.21	-1.02
Price/Book	-4.02	1.02	1.07
Price/Cash Flow	43.36	10.32	-7.20
Prices/Earnings	-53.64	-51.89	111.94
Price/Sales	-12.53	2.07	2.36
Price/FCF	43.36	10.32	-7.20
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q3	Δ in %
Gross Profit Margin	2.00	0.07	0.07
Operating Margin	-55.33	< 0.005	0.01
ROA	119.46	< 0.005	< 0.005
ROE	< 0.005	< 0.005	107.05
ROIC	< 0.005	< 0.005	478.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q3	Δ in %
Debt QOQ	-0.31	0.39	-21.21
Dividends QOQ	0.04	-0.01	-61.63
EBIT QOQ	1.17	-1.41	20.32
EPS QOQ	1.10	-2.42	121.18
FCF QOQ	-3.80	2.60	-31.38
Revenue QOQ	-0.16	0.01	-93.05
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q1	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	69.74	40.77	-41.55
Days Sales Outstanding (DSO)	19.65	28.99	47.50
Inventory Turnover	1.29	2.21	71.07
Debt/Capitalization	0.33	0.27	-18.56
Quick Ratio	0.34	0.81	137.99
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q3	Δ in %
Book Value	5.62	5.86	4.27
Cash	0.68	0.90	31.22
Capex	-0.07	0.06	-8.79
Free Cash Flow	-0.83	0.56	-32.69
Revenue	2.54	2.80	10.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q3	Δ in %
Current Ratio	1.13	1.20	5.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	25.30	103.71	309.84
Naive Interpretation	Member

06 - Financial Health · Bad

Rating